
Pat-CR 37.5 Tablet
Marketer
V.M.S Pharma
Salt Composition
Paroxetine (37.5mg)
Overview Pat-CR 37.5 Tablet
Sertraline 37.5 mg extended-release tablets are an SSRI antidepressant frequently used to manage depression and related anxiety disorders such as obsessive-compulsive disorder and panic attacks. This medication assists many patients in recovering from depressive symptoms by elevating mood and alleviating anxiety and tension. It can be administered with or without food. Dosage and frequency are determined individually by your physician to optimize symptom control, often starting with a lower dose gradually increased as needed. Never alter your dosage or discontinue use without consulting your doctor; abrupt cessation can worsen your condition or trigger unpleasant withdrawal effects (including anxiety, restlessness, rapid heartbeat, dizziness, sleep problems, etc.). For optimal results, take this medication consistently at the same time daily; morning administration may be preferred if sleep disturbances occur. Significant improvement may take several weeks. Report lack of progress after four weeks of treatment. Common side effects include nausea, tiredness, dry mouth, appetite changes, increased perspiration, dizziness, nervousness, tremors, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately notify your doctor of any sudden mood worsening or suicidal thoughts. Before commencing treatment, inform your physician if you have epilepsy, diabetes, liver or kidney disease, cardiac conditions, or glaucoma, as these may influence treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Interactions with other medications, particularly other antidepressants and MAO inhibitors, are possible; always disclose all medications you are taking to ensure safety.
Primary Ingredients of Pat-CR 37.5 Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Pat-CR 37.5 Tablet
Managing depressive disorders | Addressing panic attacks and panic disorder | Anxiety disorder management
Major Benefits of Pat-CR 37.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Pat-CR 37.5 Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Pat-CR 37.5 Tablet:
- Nausea
- Fatigue
- Dryness in mouth
- Loss of appetite
- Increased sweating
- Dizziness
- Nervousness
- Tremors
- Low sexual desire
- Insomnia (difficulty in sleeping)
- Confusion
- Constipation
- Erectile dysfunction
- Delayed ejaculation
- Decreased libido
How to use Pat-CR 37.5 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption of Pat-CR 37.5 Tablet may coincide with meals or be taken independently, however, consistent timing is recommended.
How Pat-CR 37.5 Tablet works:
Pat-CR 37.5mg tablets contain a selective serotonin reuptake inhibitor (SSRI) that counteracts depression. The medication elevates serotonin, a neurotransmitter crucial for mood regulation, thus alleviating depressive symptoms, both emotional and physical, and also offering relief from panic disorder, anxiety, and obsessive-compulsive symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Pat-CR 37.5 Tablet is dangerous.
PregnancyUNSAFE
Use of Pat-CR 37.5 Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal and human studies indicates substantial risks to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The use of Pat-CR 37.5 Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Pat-CR 37.5 Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Pat-CR 37.5 Tablets. Dosage modification may be necessary; physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise prudence when using Pat-CR 37.5 mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Pat-CR 37.5 Tablet :
Should you forget a Pat-CR 37.5 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Pat-CR 37.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperidine Phenyl Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavioral Class | Selective serotonin reuptake inhibitors (SSRIs) |
